David James
Associate Principal Scientist Merck & Co
David James is an Associate Principal Scientist at Merck working in the areas of Analytical R&D, Cell-Based Sciences, and CMC. He is a potency team representative and works across both oncology and ophthalmology therapeutic areas. He previously progressed through multiple roles at Novartis, completed a Post-Doctoral Fellowship at New York University School of Medicine, and gained his PhD in Microbiology at the University of Alabama at Birmingham.
Seminars
Tuesday 15th September 2026
Group Roundtable Discussions
3:00 pm
- Roundtable discussions are designed to be interactive, discursive deep dives where delegates break into smaller groups to explore a focused topic through candid, peer-led conversation. Each group will exchange experiences, challenges, and practical insights before reconvening to share key takeaways with the wider audience and with the conversation being facilitated by our seminar day leaders.
Tuesday 15th September 2026
Considerations of Potency Strategies & Assay Development for Multi- Specific Biologics
1:30 pm
- Strategies for designing and optimizing cell based potency assays for complex multi target biologics
- Case studies highlighting analytical challenges, assay robustness, and orthogonal approaches
- Lessons learned on how analytical data can inform formulation and process development decisions
